Skip to main content
Immutep Limited (ASX:IMM)
Australia flag Australia · Delayed Price · Currency is AUD
0.260
+0.005 (1.96%)
At close: Dec 5, 2025

Immutep Revenue

In the fiscal year ending June 30, 2025, Immutep had annual revenue of 5.04M AUD with 31.28% growth. Immutep had revenue of 1.90M in the half year ending June 30, 2025, with 4.17% growth.

Revenue
5.04M
Revenue Growth
+31.28%
P/S Ratio
75.88
Revenue / Employee
162.70K
Employees
31
Market Cap
382.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20255.04M1.20M31.28%
Jun 30, 20243.84M336.16K9.59%
Jun 30, 20233.51M-1.21M-25.64%
Jun 30, 20224.71M851.56K22.04%
Jun 30, 20213.86M-9.88M-71.88%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 23.73B
Pro Medicus 212.98M
Cochlear 2.34B
Sonic Healthcare 9.65B
Ramsay Health Care 17.79B
Ansell 3.06B
Telix Pharmaceuticals 1.01B
Mesoblast 26.23M
Revenue Rankings

Immutep News

More News